Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. Pittock SJ, Fujihara K, Palace J, Berthele A, et al. Mult Scler 2022;28:480-486.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pittock SJ, Fujihara K, Palace J, Berthele A, et al. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. Mult Scler 2022;28:480-486.
PMID: 34498507